EA033501B1 - Method for differential diagnostics of an early or pronounced stage of rheumatoid arthritis with oesteoarthritis - Google Patents
Method for differential diagnostics of an early or pronounced stage of rheumatoid arthritis with oesteoarthritisInfo
- Publication number
- EA033501B1 EA033501B1 EA201800225A EA201800225A EA033501B1 EA 033501 B1 EA033501 B1 EA 033501B1 EA 201800225 A EA201800225 A EA 201800225A EA 201800225 A EA201800225 A EA 201800225A EA 033501 B1 EA033501 B1 EA 033501B1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- rheumatoid arthritis
- oesteoarthritis
- early
- stage
- differential diagnostics
- Prior art date
Links
Landscapes
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
The invention relates to the method for differential diagnostics of rheumatoid arthritis and oesteoarthritis. Particularity of the method is that it enables determining the stage of rheumatoid arthritis and oesteoarthritis (early or pronounced) in addition to differential diagnostics of either condition. The innovative feature of the method consists in diagnosing the disease using the analysis of patient's blood heparin plasma thus determining the dynamics of typical, abnormal and minor forms of butyrylcholinesterase (BChE) ferment with the account of the indicators of its dynamics, thus differentiating between either the early stage of rheumatoid arthritis or the advanced stage of rheumatoid arthritis, or oesteoarthritis.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EA201800225A EA033501B1 (en) | 2018-04-03 | 2018-04-03 | Method for differential diagnostics of an early or pronounced stage of rheumatoid arthritis with oesteoarthritis |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EA201800225A EA033501B1 (en) | 2018-04-03 | 2018-04-03 | Method for differential diagnostics of an early or pronounced stage of rheumatoid arthritis with oesteoarthritis |
Publications (3)
Publication Number | Publication Date |
---|---|
EA201800225A2 EA201800225A2 (en) | 2018-10-31 |
EA201800225A3 EA201800225A3 (en) | 2018-12-28 |
EA033501B1 true EA033501B1 (en) | 2019-10-31 |
Family
ID=63917762
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA201800225A EA033501B1 (en) | 2018-04-03 | 2018-04-03 | Method for differential diagnostics of an early or pronounced stage of rheumatoid arthritis with oesteoarthritis |
Country Status (1)
Country | Link |
---|---|
EA (1) | EA033501B1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2735738C1 (en) * | 2019-12-24 | 2020-11-06 | Федеральное государственное бюджетное научное учреждение "Научно-исследовательский институт фундаментальной и клинической иммунологии" | Method for early diagnosis of rheumatoid arthritis |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2414836A2 (en) * | 2009-03-30 | 2012-02-08 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Biomarkers, methods and kits for the diagnosis of rheumatoid arthritis |
RU2566718C2 (en) * | 2013-12-30 | 2015-10-27 | Государственное бюджетное образовательное учреждение Дополнительного профессионального образования "Пензенский институт усовершенствования врачей" Минздрава России (ГБОУ ДПО ПИУВ Минздрава России) | Method of prenosological assessment of impairment of protein synthesis liver function in children by activity of cholinesterase enzyme |
-
2018
- 2018-04-03 EA EA201800225A patent/EA033501B1/en not_active IP Right Cessation
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2414836A2 (en) * | 2009-03-30 | 2012-02-08 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Biomarkers, methods and kits for the diagnosis of rheumatoid arthritis |
RU2566718C2 (en) * | 2013-12-30 | 2015-10-27 | Государственное бюджетное образовательное учреждение Дополнительного профессионального образования "Пензенский институт усовершенствования врачей" Минздрава России (ГБОУ ДПО ПИУВ Минздрава России) | Method of prenosological assessment of impairment of protein synthesis liver function in children by activity of cholinesterase enzyme |
Non-Patent Citations (1)
Title |
---|
СТАРОСТИНА В.К. и др. Холинэстераза: диагностическое значение и методы анализа. Лабораторная диагностика. Поликлиника, 2010, 3, с. 26-29 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2735738C1 (en) * | 2019-12-24 | 2020-11-06 | Федеральное государственное бюджетное научное учреждение "Научно-исследовательский институт фундаментальной и клинической иммунологии" | Method for early diagnosis of rheumatoid arthritis |
Also Published As
Publication number | Publication date |
---|---|
EA201800225A2 (en) | 2018-10-31 |
EA201800225A3 (en) | 2018-12-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2018012580A (en) | Methods and kits for the diagnosis and risk stratification of patients with ischemia. | |
Russo et al. | Hyperhomocysteinemia is associated with cognitive impairment in multiple sclerosis | |
EP4234710A3 (en) | Method for accurate diagnosis of a disease targeting biomarkers in liquid biopsy | |
WO2018037229A8 (en) | Clinical diagnosis of non-alcoholic fatty liver disease using a panel of human blood protein biomarkers | |
EA201991455A1 (en) | COMPOSITIONS AND METHODS FOR TREATING ALPHA-1-ANTITRIPSIN DEFICIENCY | |
MA44971B1 (en) | Fracture analysis apparatus and method | |
WO2018157191A8 (en) | Method of scanning and assessing lung and vascular health | |
EA033501B1 (en) | Method for differential diagnostics of an early or pronounced stage of rheumatoid arthritis with oesteoarthritis | |
MX2019013589A (en) | Detection of misfolded tau protein. | |
WO2018026969A3 (en) | Plazomicin antibodies and methods of use | |
WO2018202931A3 (en) | Method for diagnosis of unstable atherosclerotic plaques | |
GB2569932A (en) | Identification and use of very long chain dicarboxylic acids for disease diagnosis, chemoprevention, and treatment | |
EA201792690A1 (en) | THE METHOD OF AUTOMATIC DIAGNOSTICS OF THE CONDITION OF THE OBJECT AND SYSTEM FOR THE IMPLEMENTATION OF THE METHOD | |
WO2015115923A3 (en) | A profile of microrna in the blood as a test for the detection of lung cancer | |
WO2015060703A3 (en) | Kit for diagnosing chronic myeloid leukaemia in a multiplex reaction and applications of same to monitor the treatment and the residual disease | |
WO2005039487A3 (en) | Method for early detection of ovarian cancer | |
Díaz‐Pollán et al. | Lp‐PLA2 levels in HIV‐infected patients | |
Golden et al. | Validity of VHA Administrative Data to Determine Accurate Smoking Status | |
MX2022004558A (en) | Coagulation assay apparatus and methods thereof. | |
De-la-Iglesia et al. | Psychosocial factors in Autism Spectrum Disorder: Anxiety and depressive disorders | |
Mal'chevskiĭ | Character of changes in the rheological parameters of blood in patients with heart failure III-IV FC treated by the combination therapy with plasmapheresis | |
Huh | Reproducibility of Hypothesis Testing and Confidence Interval | |
Cresp-Barria et al. | Correlating anthropometric variables as health predictors in a group of children and adolescents suffering Down's syndrome in Temuco, Chile | |
MX2024006686A (en) | In vitro method for the diagnosis and/or prognosis of multiple sclerosis. | |
BR112022010472A2 (en) | METHOD FOR PREDICTING BIOLOGICAL THERAPY REQUIREMENTS |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s) |
Designated state(s): TM |